The Queensland Government is now in caretaker mode until after the state election. Minimal updates will be made to this site until after the election results are declared.

Skip links and keyboard navigation

J&J QuickFire winners to innovate and commercialise in Queensland

A new hope in the fight against Alzheimer’s disease, a promising new way to tackle gum disease and a low-cost medical device that could revolutionise the diagnosis of heart damage are the recipients of the inaugural Advance Queensland Johnson & Johnson Innovation QuickFire Challenge.

The three winners were selected from a pool of nearly 100 applicants and will each receive $100,000 to be spent in Queensland on research and development and commercialisation services that progress their healthcare innovations.

The successful recipients are:

  • Medical Devices category: Sydney-based Atomo Diagnostics is developing a prototype device for the early detection of cardiac damage. The device is based on Atomo Diagnostics’ AtomoRapid Point-of-Care technology and will utilise cardiac markers developed by Brisbane-based Anteo Technologies.
  • Pharmaceuticals category: Taiwan-based Golden Biotechnology Corporation will look to do pre-clinical testing of a chemical compound, called Antroquinonol, which provides hope as a possible drug for the treatment of Alzheimer’s disease.
  • Consumer devices category: Using nanotechnology, Melbourne-based Eikonic R&D Pty Ltd has identified a chemical compound that targets the class of bacteria responsible for gum disease and tooth decay.
Winners of the J&J Innovation QuickFire Challenge

Left to right: Ingrid Rodriguez from Eikonic R&D (winner of consumer health category), Miles Chen and Howard Cheng from Golden Biotechnology Corporation (winner of pharmaceutical), John Kelly and Melissa Webster from Atomo Diagnostics (winner of medical devices category).

The winners were announced at the new Johnson & Johnson Innovation Partnering Office at QUT that will provide access to commercialisation expertise, mentoring and support to nurture and accelerate Queensland’s life sciences industry and build our reputation as a global health innovation leader.

The new Johnson & Johnson Innovation Partnering Office at QUT is located at the Institute of Health and Biomedical Innovation in Brisbane.

Read the media release on the announcement.

To find out more or to get involved, contact:

Licence
Creative Commons Attribution-NoDerivs 3.0 Australia (CC BY-ND 3.0)
Last updated
18 July, 2017

Call us

13 QGOV (13 74 68)

Page feedback

  1. How satisfied are you with your experience today? *
Scroll to top